Cello Health (CLL)

Sector:

Health Care

Index:

FTSE AIM All-Share

 137.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 148.00p
  • 52 Week Low: 102.50p
  • Currency: UK Pounds
  • Shares Issued: 106.23m
  • Volume: 11,253
  • Market Cap: £146.07m
  • RiskGrade: 129

Cello Health Overview

Cello Health is in the health care sector and is currently trading at 137.50p per share. In the last year Cello Health's share price has ranged from 102.50p to 148.00p and brokers are currently rating this stock as 'buy'.

Key Personnel

CEO: Mark Scott
Executive Director: Julia Ralston
Group COO: Stephen Highley
Group Finance Director: Mark Bentley
Independent Non-Executive Director: Jo LeCouilliard
Independent Non-Executive Director: Clifford Tompsett
Non-Executive Chairman: Christopher Jones
Non-Executive Dir: Michele Luzi

Contact Details

Address: Queens House, 8-9 Queen Street, London, United Kingdom, EC4N 1SP
Phone: +44 (0)20 7812 8460
Fax: +44 (0)20 7253 5376

Listings

Sector: Health Care(LSE)
Index: FTSE AIM All-Share
ISIN: GB00B0310763

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Cello Health Market Data

Currency UK Pounds
Share Price 137.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 148.00p
52 Week Low 102.50p
Volume 11,253
Shares Issued 106.23m
Market Cap £146.07m
RiskGrade 129

Cello Health Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
58.18% below the market average58.18% below the market average58.18% below the market average58.18% below the market average58.18% below the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
Price Trend
63.14% above the market average63.14% above the market average63.14% above the market average63.14% above the market average63.14% above the market average
55.00% above the sector average55.00% above the sector average55.00% above the sector average55.00% above the sector average55.00% above the sector average
Income
21.13% above the market average21.13% above the market average21.13% above the market average21.13% above the market average21.13% above the market average
57.14% above the sector average57.14% above the sector average57.14% above the sector average57.14% above the sector average57.14% above the sector average
Growth
30.48% below the market average30.48% below the market average30.48% below the market average30.48% below the market average30.48% below the market average
47.06% below the sector average47.06% below the sector average47.06% below the sector average47.06% below the sector average47.06% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 2
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Cello Health Dividends

  Latest Previous
  Interim Final
Ex-Div 03-Oct-19 25-Apr-19
Paid 01-Nov-19 24-May-19
Amount 1.15p 2.75p

Trades for 24-Jan-2020

Time Volume / Share Price
14:59 4,000 @ 136.50p
14:10 13 @ 138.60p
11:03 760 @ 136.16p
09:33 6,480 @ 138.60p

Cello Health Key Personnel

CEO Mark Scott

Top of Page